Confirmatory validation of the french version of the Duchenne Muscular Dystrophy module of the pediatric quality of life inventory (PedsQL


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
15 11 2023
Historique:
received: 08 08 2022
accepted: 24 06 2023
medline: 17 11 2023
pubmed: 16 11 2023
entrez: 16 11 2023
Statut: epublish

Résumé

Duchenne Muscular Dystrophy (DMD) is a neuromuscular disease that inevitably leads to total loss of autonomy. The new therapeutic strategies aim to both improve survival and optimise quality of life. Evaluating quality of life is nevertheless a major challenge. No DMD-specific quality of life scale to exists in French. We therefore produced a French translation of the English Duchenne Muscular Dystrophy module of the Pediatric Quality of Life Inventory (PedsQL

Identifiants

pubmed: 37968589
doi: 10.1186/s12887-023-04153-4
pii: 10.1186/s12887-023-04153-4
pmc: PMC10647061
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

563

Informations de copyright

© 2023. The Author(s).

Références

Health Qual Life Outcomes. 2020 Aug 3;18(1):263
pubmed: 32746836
Health Qual Life Outcomes. 2019 May 2;17(1):76
pubmed: 31046775
Nat Rev Dis Primers. 2021 Feb 18;7(1):13
pubmed: 33602943
Lancet Neurol. 2018 Apr;17(4):347-361
pubmed: 29395990
PLoS One. 2009;4(2):e4347
pubmed: 19194511
Dev Med Child Neurol. 2016 May;58(5):435-6
pubmed: 26534893
J Child Neurol. 2014 Feb;29(2):167-81
pubmed: 24352162
Molecules. 2015 Oct 07;20(10):18168-84
pubmed: 26457695
Dev Med Child Neurol. 2009 Aug;51(8):660-9
pubmed: 19627340
J Neurol. 2016 May;263(5):906-915
pubmed: 26964543
Pediatrics. 2012 Dec;130(6):e1559-66
pubmed: 23129083
Lancet Neurol. 2018 Mar;17(3):251-267
pubmed: 29395989
Arch Phys Med Rehabil. 2015 Jul;96(7):1242-7
pubmed: 25731937
Dev Med Child Neurol. 2016 May;58(5):508-15
pubmed: 26483095
Neurologia (Engl Ed). 2019 Sep;34(7):469-481
pubmed: 29526319
Nat Rev Neurol. 2019 Jul;15(7):373-386
pubmed: 31147635
Health Qual Life Outcomes. 2018 Dec 19;16(1):237
pubmed: 30567556
Health Qual Life Outcomes. 2013 Mar 15;11:47
pubmed: 23497421
J Med Genet. 2016 Mar;53(3):145-51
pubmed: 26754139
Orphanet J Rare Dis. 2020 Jun 5;15(1):141
pubmed: 32503598
Value Health. 2004 Jan-Feb;7(1):79-92
pubmed: 14720133
Neuromuscul Disord. 2005 Jul;15(7):463-70
pubmed: 16106528
J Clin Neuromuscul Dis. 2010 Mar;11(3):97-109
pubmed: 20215981

Auteurs

Elisabeth Wallach (E)

Neuropediatric Department, Toulouse-Purpan University Hospital, Toulouse, France. wallach.a@chu-toulouse.fr.

Virginie Ehlinger (V)

UMR 1295 CERPOP, Toulouse University, Inserm, University Toulouse III Paul Sabatier, Toulouse, France.

Maelle Biotteau (M)

Neuropediatric Department, Toulouse-Purpan University Hospital, Toulouse, France. maelle.biotteau@inserm.fr.
ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France. maelle.biotteau@inserm.fr.

Ulrike Walther-Louvier (U)

CHU Montpellier, Service de Neuropédiatrie, Centre de Référence Maladies Neuromusculaires AOC, Montpellier, France.

Yann Péréon (Y)

Reference Centre for Neuromuscular Diseases AOC, Filnemus, Euro-NMD, Hôtel-Dieu, CHU Nantes, Nantes, France.

Carole Vuillerot (C)

Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, L'Escale, Service de Médecine Physique et de Réadaptation Pédiatrique, Bron, France.
NeuroMyogen Institute, CNRS UMR 5310 - INSERM U1217, University of Lyon, Lyon, France.

Stephanie Fontaine (S)

Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, L'Escale, Service de Médecine Physique et de Réadaptation Pédiatrique, Bron, France.

Pascal Sabouraud (P)

Department of Paediatrics, French Reference Center for Neuromuscular Diseases, American Memorial Hospital, Reims University Hospital Center, Reims, France.

Caroline Espil-Taris (C)

CHU Pellegrin, Service de neuropédiatrie, Centre de Référence Maladies Neuromusculaires AOC, Bordeaux, France.

Jean-Marie Cuisset (JM)

Reference Centre for Neuromuscular Diseases Nord/Est/Ile-de-France, CHU Lille, Lille, France.
Department of Pediatric Neurology, CHU Lille, Lille, France.

Vincent Laugel (V)

Unité de neuropédiatrie et CIC pédiatrique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Eloïse Baudou (E)

Neuropediatric Department, Toulouse-Purpan University Hospital, Toulouse, France.

Catherine Arnaud (C)

UMR 1295 CERPOP, Toulouse University, Inserm, University Toulouse III Paul Sabatier, Toulouse, France.
Clinical Epidemiology Unit, University Hospital, Toulouse, France.

Claude Cances (C)

Neuropediatric Department, Toulouse-Purpan University Hospital, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH